The short version
13 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Diazepam
Diazepam · DIAZEPAM 5 mg/mL · Injection, Solution · Intramuscular; Intravenous · Hospira, Inc.
NDC 00409-3213-12 · 10 VIAL, MULTI-DOSE in 1 BOX / 10 mL in 1 VIAL, MULTI-DOSE · ANDA · View full market →
One drug, every price
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
ⓘ How this was built
Data sources
- CMS NADAC (pharmacy acquisition, weekly)
- CMS Part B ASP quarterly payment limits
- CMS Maximum Fair Prices (IRA negotiated, NDC-level)
- Medicare Part D Spending by Drug (data.cms.gov, name-matched)
- VA FSS / Big4 federal contract prices (va.gov, twice monthly)
- ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
- California SB-17 WAC filings (list price, per package)
Method
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
- Medicare Part B pays (ASP+6%)$6.85per billing unit (5 MG)HCPCS J3360 · Jul 1, 2026
- Part D plans paid (avg)$0.9408per dosage unitgross, before rebates — matched by drug name · 2024
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$578.73
Reported to Texas DSHS · 2026 annual filing · Pfizer Inc.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicare Part B (ASP)
Payment limit per 5 MG
$6.854
HCPCS J3360 · Jul 1, 2026 quarter · typically ASP + 6%
Medicaid spend (2025)
$16,198
322 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- Hospira, Inc.United Statesanalysis
- Hospira, Inc.United Statesanalysis · label · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $16.24 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA071583
- TE code
- AP
- Approval date
- Oct 13, 1987
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
- Class II · TerminatedAug 16, 2013Hospira Inc. — Lack of assurance of sterility: ineffective crimp on fliptop vials that may result in leaking at the neck of the vials.
- Class II · TerminatedMay 16, 2013Hospira Inc. — Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.
- Class II · TerminatedFeb 26, 2013Hospira Inc. — Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.
- Class II · TerminatedAug 28, 2012Hospira Inc. — Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.
Manufacturers of Diazepam (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Natco Pharma USA LLC | DIAZEPAM 10 mg/2mL | Jul 15, 2026 | Sep 3, 2026 |
| Remedyrepack Inc. | DIAZEPAM 10 mg/2mL | Jul 15, 2026 | Sep 3, 2026 |
| Alembic Pharmaceuticals Inc. | DIAZEPAM 10 mg/2mL | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | DIAZEPAM 10 mg/2mL | Jul 15, 2026 | Sep 2, 2026 |
| Civica, Inc. | DIAZEPAM 10 mg/2mL | Jul 15, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | DIAZEPAM 10 mg/2mL | Jul 15, 2026 | Sep 2, 2026 |
| Henry Schein, Inc. | DIAZEPAM 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | DIAZEPAM 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Natco Pharma USA LLC | DIAZEPAM 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | DIAZEPAM 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Hospira, Inc. | DIAZEPAM 5 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
| Medical Purchasing Solutions, LLC | DIAZEPAM 5 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
| Baxter Healthcare Corporation | DIAZEPAM 20 mg/4mL | Aug 7, 2026 | Aug 28, 2026 |
| Baxter Healthcare Corporation | DIAZEPAM 10 mg/2mL | Aug 7, 2026 | Aug 28, 2026 |
| Dr. Reddy's Laboratories Inc | DIAZEPAM 10 mg/2mL | Jul 15, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Diazepam — NDC 00409-3213-12," retrieved September 3, 2026, https://drugdashboards.com/drug/00409321312.
Free to cite with attribution — see how the data is put together.